Outcome and toxicity analysis of single dose stereotactic radiosurgery in vestibular schwannoma based on the Koos grading system

Abstract Stereotactic radiosurgery (SRS) has evolved as widely accepted treatment option for small-sized (Koos I up to II) vestibular schwannoma (VS). For larger tumors (prevalent Koos VI), microsurgery or combined treatment strategies are mostly recommended. However, in patients not suited for micr...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Daniel Rueß, Lea Pöhlmann, Stefan Grau, Christina Hamisch, Mauritius Hoevels, Harald Treuer, Christian Baues, Martin Kocher, Maximillian Ruge
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2020
Materias:
R
Q
Acceso en línea:https://doaj.org/article/1129e41c4c7444cfbe7f09cc4649a685
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:1129e41c4c7444cfbe7f09cc4649a685
record_format dspace
spelling oai:doaj.org-article:1129e41c4c7444cfbe7f09cc4649a6852021-12-02T17:52:42ZOutcome and toxicity analysis of single dose stereotactic radiosurgery in vestibular schwannoma based on the Koos grading system10.1038/s41598-020-66213-42045-2322https://doaj.org/article/1129e41c4c7444cfbe7f09cc4649a6852020-06-01T00:00:00Zhttps://doi.org/10.1038/s41598-020-66213-4https://doaj.org/toc/2045-2322Abstract Stereotactic radiosurgery (SRS) has evolved as widely accepted treatment option for small-sized (Koos I up to II) vestibular schwannoma (VS). For larger tumors (prevalent Koos VI), microsurgery or combined treatment strategies are mostly recommended. However, in patients not suited for microsurgery, SRS might also be an alternative to balance tumor control, hearing preservation and adverse effects. The purpose of this analysis was to evaluate the efficacy and toxicity of SRS for VS with regard to different Koos grades. All patients with untreated VS who received SRS at our center were included. Outcome analysis included tumor control, preservation of serviceable hearing based on median pure tone averages (PTA), and procedure-related adverse events rated by the Common Terminology Criteria for Adverse Events (CTCAE; v4.03) classification. In total, 258 patients (median age 58 years, range 21–84) were identified with a mean follow-up of 52 months (range 3–228 months). Mean tumor volume was 1.8 ml (range 0.1–18.5). The mean marginal dose was 12.3 Gy ± 0.6 (range 11–13.5). The cohort was divided into two groups: A (Koos grades I and II, n = 186) and B (Koos grades III and IV, n = 72). The actuarial tumor control rate was 98% after 2 years and 90% after 5 and 10 years. Koos grading did not show a significant impact on tumor control (p = 0.632) or hearing preservation (p = 0.231). After SRS, 18 patients (7%) had new transient or permanent symptoms classified by the CTCAE. The actuarial rate of CTCAE-free survival was not related to Koos grading (p = 0.093). Based on this selected population of Koos grade III and IV VS without or with only mild symptoms from brainstem compression, SRS can be recommended as the primary therapy with the advantage of low morbidity and satisfactory tumor control. The overall hearing preservation rate and toxicity of SRS was influenced by age and cannot be predicted by tumor volume or Koos grading alone.Daniel RueßLea PöhlmannStefan GrauChristina HamischMauritius HoevelsHarald TreuerChristian BauesMartin KocherMaximillian RugeNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 10, Iss 1, Pp 1-9 (2020)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Daniel Rueß
Lea Pöhlmann
Stefan Grau
Christina Hamisch
Mauritius Hoevels
Harald Treuer
Christian Baues
Martin Kocher
Maximillian Ruge
Outcome and toxicity analysis of single dose stereotactic radiosurgery in vestibular schwannoma based on the Koos grading system
description Abstract Stereotactic radiosurgery (SRS) has evolved as widely accepted treatment option for small-sized (Koos I up to II) vestibular schwannoma (VS). For larger tumors (prevalent Koos VI), microsurgery or combined treatment strategies are mostly recommended. However, in patients not suited for microsurgery, SRS might also be an alternative to balance tumor control, hearing preservation and adverse effects. The purpose of this analysis was to evaluate the efficacy and toxicity of SRS for VS with regard to different Koos grades. All patients with untreated VS who received SRS at our center were included. Outcome analysis included tumor control, preservation of serviceable hearing based on median pure tone averages (PTA), and procedure-related adverse events rated by the Common Terminology Criteria for Adverse Events (CTCAE; v4.03) classification. In total, 258 patients (median age 58 years, range 21–84) were identified with a mean follow-up of 52 months (range 3–228 months). Mean tumor volume was 1.8 ml (range 0.1–18.5). The mean marginal dose was 12.3 Gy ± 0.6 (range 11–13.5). The cohort was divided into two groups: A (Koos grades I and II, n = 186) and B (Koos grades III and IV, n = 72). The actuarial tumor control rate was 98% after 2 years and 90% after 5 and 10 years. Koos grading did not show a significant impact on tumor control (p = 0.632) or hearing preservation (p = 0.231). After SRS, 18 patients (7%) had new transient or permanent symptoms classified by the CTCAE. The actuarial rate of CTCAE-free survival was not related to Koos grading (p = 0.093). Based on this selected population of Koos grade III and IV VS without or with only mild symptoms from brainstem compression, SRS can be recommended as the primary therapy with the advantage of low morbidity and satisfactory tumor control. The overall hearing preservation rate and toxicity of SRS was influenced by age and cannot be predicted by tumor volume or Koos grading alone.
format article
author Daniel Rueß
Lea Pöhlmann
Stefan Grau
Christina Hamisch
Mauritius Hoevels
Harald Treuer
Christian Baues
Martin Kocher
Maximillian Ruge
author_facet Daniel Rueß
Lea Pöhlmann
Stefan Grau
Christina Hamisch
Mauritius Hoevels
Harald Treuer
Christian Baues
Martin Kocher
Maximillian Ruge
author_sort Daniel Rueß
title Outcome and toxicity analysis of single dose stereotactic radiosurgery in vestibular schwannoma based on the Koos grading system
title_short Outcome and toxicity analysis of single dose stereotactic radiosurgery in vestibular schwannoma based on the Koos grading system
title_full Outcome and toxicity analysis of single dose stereotactic radiosurgery in vestibular schwannoma based on the Koos grading system
title_fullStr Outcome and toxicity analysis of single dose stereotactic radiosurgery in vestibular schwannoma based on the Koos grading system
title_full_unstemmed Outcome and toxicity analysis of single dose stereotactic radiosurgery in vestibular schwannoma based on the Koos grading system
title_sort outcome and toxicity analysis of single dose stereotactic radiosurgery in vestibular schwannoma based on the koos grading system
publisher Nature Portfolio
publishDate 2020
url https://doaj.org/article/1129e41c4c7444cfbe7f09cc4649a685
work_keys_str_mv AT danielrueß outcomeandtoxicityanalysisofsingledosestereotacticradiosurgeryinvestibularschwannomabasedonthekoosgradingsystem
AT leapohlmann outcomeandtoxicityanalysisofsingledosestereotacticradiosurgeryinvestibularschwannomabasedonthekoosgradingsystem
AT stefangrau outcomeandtoxicityanalysisofsingledosestereotacticradiosurgeryinvestibularschwannomabasedonthekoosgradingsystem
AT christinahamisch outcomeandtoxicityanalysisofsingledosestereotacticradiosurgeryinvestibularschwannomabasedonthekoosgradingsystem
AT mauritiushoevels outcomeandtoxicityanalysisofsingledosestereotacticradiosurgeryinvestibularschwannomabasedonthekoosgradingsystem
AT haraldtreuer outcomeandtoxicityanalysisofsingledosestereotacticradiosurgeryinvestibularschwannomabasedonthekoosgradingsystem
AT christianbaues outcomeandtoxicityanalysisofsingledosestereotacticradiosurgeryinvestibularschwannomabasedonthekoosgradingsystem
AT martinkocher outcomeandtoxicityanalysisofsingledosestereotacticradiosurgeryinvestibularschwannomabasedonthekoosgradingsystem
AT maximillianruge outcomeandtoxicityanalysisofsingledosestereotacticradiosurgeryinvestibularschwannomabasedonthekoosgradingsystem
_version_ 1718379152923426816